Top Pharmaceuticals Startups in 2026

edX Holdings, Inc. (OTC: MEDH) is a forward-thinking company at the forefront of the cannabis industry. Through its Lazydaze brand, Smart Brand Digital agency, and innovative concepts like AI-powered Lazydaze "ON the GO" vending machines, MedX Holdings is committed to expanding its market presence, redefining the cannabis retail experience, and driving the cannabis hospitality movement in the United States. Our mission is to deliver exceptional products and unforgettable hospitality experiences through our Lazydaze +Coffeeshop brands and franchises. We are committed to leading the industry by developing and expanding a successful portfolio of licensed and franchised brands. For more information, please visit lazydazefranchise.com and follow us @medxholdings and the CEO @the1onlyhans on X Together, We Are Counterculture

SwitchOn (switchon.io) is a leading provider of Vision AI inspection solutions for the manufacturing industry. Leading global manufacturers such as Unilever, P&G, Diageo, ITC, SKF, and Tata, amongst others, are already using the SwitchOn's DeepInspect platform in multiple sites globally and have experienced lower product wastages, improvements in costs and efficiency, as well as upholding brand quality. Our product is converging Industrial IoT and AI to solve some of the most difficult problems in the manufacturing sector.

Manifold is a leading research cloud built for life sciences. Biomedical research is now about data of increasing scale, modality, velocity, and complexity. It is also inherently collaborative. The old tools aren’t working. Manifold gives researchers a single place to collect, harmonize, and analyze life sciences data, without having to set up compute infrastructure, do complex data integrations and prep, or hire a large software team.

With an expanding portfolio of intellectual property and interdisciplinary technical expertise, Peptineo represents the new face of biotechnology and bioengineering. By employing a systems-based approach, Peptineo technical solutions involve drug delivery combinations including “tunable” nano-carriers, engineered peptides, re-formulated pharmaceuticals, and as appropriate, recombinant proteins. Additionally, Peptineo is developing technologies that will greatly enhance and accelerate the drug discovery process. To that end, we are developing solutions that reflect research efforts in computer science, systems biology, physics, molecular biology, pharmacology, protein engineering and biotechnology. It is our belief that by having a broad range of technology and scientific expertise at our disposal, we will have the resources required to efficiently address current or evolving clinical demands.

Verantos is the market leader in high-validity real-world evidence for life sciences. By incorporating robust clinical narrative data, artificial intelligence technology, and measured validity, Verantos is the first company to generate research-grade evidence at scale across all therapeutic areas. The Verantos Evidence Platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for market access, HEOR, medical affairs, and regulatory use.

We have extensive expertise in method development, validation, and transfer, mass spectrometric and chromatographic (LC-MS) bioanalysis, pharmacokinetics (PK) sample analysis, toxicokinetic safety testing, as well as other custom assay services. Our assay services include ELISA based assay, cell-based assay, biomarker testing, immunogenicity testing, biochemical assay, and Mechanism of Action (MoA) studies.

The protocol enables new economic incentive models for distributed research and development. We leverage open science and blockchain technology to create a fair and accountable market-based platform for discovery and funding of pharmaceutical intellectual property. The ecosystem aims to align all stakeholders - academia, pharmaceutical corporations, consumers, biotech companies, investors, regulators, and lawyers - to collaborate in an open, incentive-based market.

Machine learning-enabled platform for drug discovery and development.

Pulse, are the leading global provider of multichannel marketing content creation and automation and artificial intelligence technology, for life science companies. Using our customer centric approach, combined with compelling creative and groundbreaking technology, we work with some of the worlds largest healthcare organisations to create remarkable experiences for healthcare professionals and patients. Our CLM builder platform, Heartbeat™, is a cloud-based, multichannel marketing automation platform – optimised for Veeva customers and adopted by leading global pharmaceutical companies. Heartbeat™ seamlessly integrates into Veeva Vault and automates common tasks across the end-to-end content supply chain for CLM, Engage, Approved Email and MyInsights. We are at the cutting edge of transforming healthcare for the benefit of patients. We are always on the lookout for talented individuals to come and help us drive the change.